Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Zhe, Shi, Lei, Wang, Yijin, Zhang, Jiyuan, Huang, Lei, Zhang, Chao, Liu, Shuhong, Zhao, Peng +10 more·2020·The Lancet Respiratory Medicine

Cited by (1,023)

Items 801–900 of 1,023

  1. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID‐19): A multicenter, cross‐sectional study
    Junnan Peng, Di Qi, Guodan Yuan, Xinyu Deng, Ying Mei, Longhua Feng, Daoxin Wang · 2020 · Journal of Clinical Laboratory Analysis
  2. The role of Interleukin 6 inhibitors in therapy of severe COVID-19
    Evgeny Lvovich Nasonov, Samsonov MIu · 2020 · Biomedicine & Pharmacotherapy
  3. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
    Richard H. Hunt, James Edward East, Ángel Lanas, Peter Malfertheiner, Jack J. Satsangi, Carmelo Scarpignato, Gwilym James Webb · 2020 · Digestive Diseases
  4. T cell immunobiology and cytokine storm of COVID‐19
    Xiao-Hua Luo, Yan Zhu, Jian Mao, R. Du · 2020 · Scandinavian Journal of Immunology
  5. The role of IL-6 and IL-6 blockade in COVID-19
    Nicola Potere, Alberto Batticciotto, Alessandra Vecchié, Ettore Porreca, Antonella Cappelli, Antonio Abbate, Francesco Dentali, Aldo Bonaventura · 2021 · Expert Review of Clinical Immunology
  6. Cardiometabolic Traits, Sepsis, and Severe COVID-19
    Mark Ponsford, Apostolos Gkatzionis, Venexia M. Walker, Andrew J. Grant, Robyn E. Wootton, Luke S. P. Moore, Segun Fatumo, Amy M. Mason, Verena Zuber, Cristen J. Willer et al. · 2020 · Circulation
  7. Mesenchymal stem cell therapy for severe COVID-19
    Lei Shi, Lifeng Wang, Ruonan Xu, Chao Zhang, Yunbo Xie, Kai Liu, Tiantian Li, Wei Hu, Cheng Zhen, Fu‐Sheng Wang · 2021 · Signal Transduction and Targeted Therapy
  8. Chest CT Patterns from Diagnosis to 1 Year of Follow-up in Patients with COVID-19
    Feng Pan, Lian Yang, Bo Liang, Tianhe Ye, Lingli Li, Lin Li, Dehan Liu, Jiazheng Wang, Richard Lindsay Hesketh, Chuansheng Zheng · 2021 · Radiology
  9. Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
    Jesús Villar, Marco Confalonieri, Stephen M. Pastores, Gianfranco Umberto Meduri · 2020 · Critical Care Explorations
  10. COVID-19 and Myocarditis: What Do We Know So Far?
    Ashar Pirzada, Ahmed T. Mokhtar, Andrew Moeller · 2020 · CJC Open
  11. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
    Xiaorong Peng, Jing Ouyang, Stéphane Isnard, John Chia-Yang Lin, Brandon Fombuena, Biao Zhu, Jean‐Pierre Routy · 2020 · Frontiers in Immunology
  12. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19
    Wafa Sayah, Ismahane Berkane, Imène Guermache, Mohamed Sabri, Fatma Zahra Lakhal, Sarah Yasmine Rahali, Asma Djidjeli, Lydia Lamara Mahammed, Fatma Merah, Brahim Belaid et al. · 2021 · Cytokine
  13. Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial
    Xiaowei Xu, Wanli Jiang, Lijun Chen, Zhenyu Xu, Qiang Zhang, Mengfei Zhu, Peng Ye, Hang Li, Liang Yu, Xiaoyang Zhou et al. · 2021 · Clinical and Translational Medicine
  14. No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science
    Monica Salerno, Francesco Sessa, Amalia Piscopo, Angelo Montana, Marco Torrisi, Federico Giuseppe Patanè, Paolo Murabito, Giovanni Li Volti, Cristoforo Pomara · 2020 · Journal of Clinical Medicine
  15. Correlates of Perceived Physical Activity Transitions during the COVID‐19 Pandemic among Canadian Adults
    Ryan E. Rhodes, Sam Liu, Alexander Lithopoulos, Chun‐Qing Zhang, Mauricio A. García-Barrera · 2020 · Applied Psychology Health and Well-Being
  16. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID‐19
    Chi Zhang, Zhao Wu, Jia‐Wen Li, Kangan Tan, Wanna Yang, Hong Zhao, Gui‐Qiang Wang · 2020 · Journal of Medical Virology
  17. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage
    Florian Reizine, Mathieu Lesouhaitier, Murielle Grégoire, Kieran Pinceaux, Arnaud Gacouin, Adel Maamar, Benoît Painvin, Christophe Camus, Yves Le Tulzo, Pierre Tattevin et al. · 2021 · Journal of Clinical Immunology
  18. Inspiratory muscle training for recovered COVID-19 patients after weaning from mechanical ventilation
    Ahmed M. Abodonya, Walid Kamal Abdelbasset, Elsayed A. Awad, Ibrahim Elalfy, Hosni Ali Salem, Shereen Hamed ELSAYED · 2021 · Medicine
  19. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
    Rajendra Karki, Thirumala‐Devi Kanneganti · 2022 · Journal of Translational Medicine
  20. Acute lung injury in patients with COVID‐19 infection
    Liyang Li, Qihong Huang, Diane C. Wang, David H. Ingbar, Xiangdong Wang · 2020 · Clinical and Translational Medicine
  21. Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c)
    Randall D. Craver, Samantha Huber, Marrianna Sandomirsky, Dwight McKenna, John S. Schieffelin, Leron Finger · 2020 · Fetal and Pediatric Pathology
  22. Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19
    Aditi Banerjee, Steven J. Czinn, Russel Joseph Reiter, Thomas G. Blanchard · 2020 · Life Sciences
  23. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
    Qiyue Ding, Nataliia V. Shults, Sergiy G. Gychka, Brent T. Harris, Yuichiro Suzuki · 2021 · International Journal of Molecular Sciences
  24. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome
    Anna Mikhailovna Kosyreva, Dzhuliia Sh. Dzhalilova, А. V. Lokhonina, Polina Vishnyakova, Timur Fatkhudinov · 2021 · Frontiers in Immunology
  25. Personal protective equipment (PPE) pollution associated with the COVID-19 pandemic along the coastline of Agadir, Morocco
    Mohamed Ben-Haddad, Gabriel Enrique De-la-Torre, Mohamed Rida Abelouah, Sara Hajji, Aicha Ait Alla · 2021 · The Science of The Total Environment
  26. Oncology Nursing During a Pandemic: Critical Reflections in the Context of COVID-19
    Catherine C. Paterson, Barbara Holmes Gobel, Tracy Gosselin, Pamela J. Haylock, Constantina Papadopoulou, Kim Slusser, Anna Liza Rodriguez, Edith Pituskin · 2020 · Seminars in Oncology Nursing
  27. Microvascular thrombosis: experimental and clinical implications
    Monica A. Bray, Sarah E. Sartain, Jahnavi Gollamudi, Rolando E. Rumbaut · 2020 · Translational research
  28. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes
    Ziliang Zhou, Chunliu Huang, Zhechong Zhou, Zhaoxia Huang, Lili Su, Sisi Kang, Xiaoxue Chen, Qiuyue Chen, Suhua He, Rong Xia et al. · 2021 · iScience
  29. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver
    Han-Yu Lei, Yinghe Ding, Kai Nie, Yin-Miao Dong, Jia-Hao Xu, Meng-Ling Yang, Meng-Qi Liu, Le Wei, MI Nasser, Lin-Yong Xu et al. · 2020 · Biomedicine & Pharmacotherapy
  30. Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation
    Shiba Prasad Dash, Saloni Gupta, Pranita P. Sarangi · 2024 · Heliyon
  31. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic
    Evgeny V. Shlyakhto, А. О. Конради, G. P. Arutyunov, A. G. Arutyunov, А. Е. Баутин, Sergey Anatol'evich Boytsov, Виллевальде Светлана Вадимовна, N. Yu. Grigorieva, Dmitry Viktorovich Duplyakov, Н. Э. Звартау et al. · 2020 · Russian Journal of Cardiology
  32. Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
    Hua Li, Zhe Liu, Junbo Ge · 2020 · Journal of Cellular and Molecular Medicine
  33. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
    Siyi Xin, Xueqi Cheng, Bo Zhu, Xiaolong Liao, Feng Yang, Lina Song, Yan Xia Shi, Xuefeng Guan, Renyi Su, Jian Wang et al. · 2020 · Biomedicine & Pharmacotherapy
  34. A cross-talk between epithelium and endothelium mediates human alveolar–capillary injury during SARS-CoV-2 infection
    Peng Wang, Rong‐Hua Luo, Min Zhang, Yaqing Wang, Tian‐Zhang Song, Tingting Tao, Zhongyu Li, Lin Jin, Hong‐Yi Zheng, Wenwen Chen et al. · 2020 · Cell Death and Disease
  35. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection
    Zhuo Long Zhou, Xinyi Zhang, Xiaobo Lei, Xia Xiao, Tao Jiao, Ruiyi Ma, Xiaojing Dong, Qi Jiang, Wenjing Wang, Yujin Shi et al. · 2021 · Signal Transduction and Targeted Therapy
  36. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke
    Qingxue Xu, Bo Zhao, Yingze Ye, Yina Li, Yonggang Zhang, Xiaoxing Xiong, Lijuan Gu · 2021 · Journal of Neuroinflammation
  37. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
    Alberto Pérez‐Gómez, Joana Vitallé, Carmen Gasca‐Capote, Alicia Gutiérrez‐Valencia, María Trujillo‐Rodríguez, Ana Serna‐Gallego, Esperanza Muñoz‐Muela, María Reyes Jiménez‐León, Mohammed Rafii‐El‐Idrissi Benhnia, Inmaculada Rivas‐Jeremías et al. · 2021 · Cellular and Molecular Immunology
  38. Long-Term Effects of COVID-19
    Shreeya R. Joshee, Nikhil Vatti, Christopher Chia-Chi Chang · 2022 · Mayo Clinic Proceedings
  39. Little to no expression of angiotensin‐converting enzyme‐2 on most human peripheral blood immune cells but highly expressed on tissue macrophages
    Song, Xiang, Hu, Wei, Yu, Haibo, Zhao, Laura, Zhao, Yeqian, Zhao, Xin, Xue, Hai‐Hui, Zhao, Yong · 2023 · Cytometry Part A
  40. SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences
    Melika Lotfi, Nima Rezaei · 2020 · Journal of Medical Virology
  41. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action
    Hassan Yousefi, Ladan Mashouri, Samuel C. Okpechi, Nikhilesh V. Alahari, Suresh K. Alahari · 2020 · Biochemical Pharmacology
  42. SARS-CoV-2 leads to a small vessel endotheliitis in the heart
    Umberto Macciò, Annelies Sophie Zinkernagel, Srikanth Mairpady Shambat, Xiankun Zeng, Gieri Cathomas, Frank Thomas Ruschitzka, Reto Andreas Schuepbach, Holger Moch, Zsuzsanna Varga · 2021 · EBioMedicine
  43. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update
    Jerry J. Lou, Mehrnaz Movassaghi, Dominique E. Gordy, Madeline G. Olson, Ting Zhang, Maya S. Khurana, Zesheng Chen, Mari A. Perez-Rosendahl, Samasuk Thammachantha, Elyse J. Singer et al. · 2020 · Free Neuropathology
  44. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
    Stefanie Deinhardt‐Emmer, Daniel Wittschieber, Juliane Sanft, Sandra Kleemann, Stefan Elschner, Karoline Frieda Haupt, Vanessa Vau, Clio Häring, Jürgen Rödel, Andreas Henke et al. · 2021 · eLife
  45. Small molecules in the treatment of COVID-19
    Sibei Lei, Xiaohua Chen, Jieping Wu, Xingmei Duan, Ke Men · 2022 · Signal Transduction and Targeted Therapy
  46. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
    Huilan Zhang, Cong‐Yi Wang, Peng Zhou, Huihui Yue, Ronghui Du · 2020 · Annals of Internal Medicine
  47. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course
    Rashika Bansal, Sriram Gubbi, Ranganath Muniyappa · 2020 · Endocrinology
  48. COVID‐19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes
    Kahindo P. Muyayalo, Donghui Huang, Si‐Jia Zhao, Ting Xie, Gil Mor, Aihua Liao · 2020 · American Journal of Reproductive Immunology
  49. Pathogenesis, Clinical Manifestations and Complications of COVID-19
    Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh · 2020 · Future Microbiology
  50. The Clinical Characteristics and Risk Factors of Severe COVID-19
    Jianhua Hu, Yanggan Wang · 2021 · Gerontology
  51. An update to monoclonal antibody as therapeutic option against COVID-19
    Paroma Deb, Md. Maruf Ahmed Molla, KM Saif‐Ur‐Rahman · 2021 · Biosafety and Health
  52. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2
    Shima Shahbaz, Lai Xu, Mohammed S. Osman, Wendy Sligl, Justin A. Shields, Michael Joyce, D. Lorne Tyrrell, Olaide Oyegbami, Shokrollah Elahi · 2021 · Stem Cell Reports
  53. Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
    Shuyu Shou, Menghui Liu, Yang Yang, Ning Kang, Yingying Song, Dan Tan, Nan-Nan Liu, Feifei Wang, Jing Liu, You-Hua Xie · 2021 · Frontiers in Microbiology
  54. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection
    Alquisiras-Burgos, Iván, Peralta-Arrieta, Irlanda, Alonso-Palomares, Luis Antonio, Zacapala-Gómez, Ana Elvira, Salmerón-Bárcenas, Eric Genaro, Aguilera, Penélope · 2021 · Molecular Neurobiology
  55. Saliva—Friend and Foe in the COVID-19 Outbreak
    Pingping Han, Sašo Ivanovski · 2020 · Diagnostics
  56. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
    Satyajit Tripathy, Barsha Dassarma, Somenath Roy, Hlupheka P. Chabalala, Motlalepula Gilbert Matsabisa · 2020 · International Journal of Antimicrobial Agents
  57. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2
    Alex Renn, Ying Fu, Xin Hu, Matthew D. Hall, Anton M. Simeonov · 2020 · Trends in Pharmacological Sciences
  58. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19
    Adeleh Sahebnasagh, Fatemeh Saghafi, Mohammadreza Safdari, Masoud Khataminia, Afsaneh Sadremomtaz, Zeinab Talaei, Hassan Rezai Ghaleno, Mahdi Bagheri, Solomon Habtemariam, Razieh Avan · 2020 · Journal of Clinical Pharmacy and Therapeutics
  59. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
    Alessandra Sacchi, Germana Grassi, Veronica Bordoni, Patrizia Lorenzini, Eleonora Cimini, Rita Casetti, Eleonora Tartaglia, Luisa Marchioni, Nicola Petrosillo, Fabrizio Palmieri et al. · 2020 · Cell Death and Disease
  60. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
    Jinghua Lu, Peter D. Sun · 2020 · Journal of Biological Chemistry
  61. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
    Flor M. Muñoz, Jakob P. Cramer, Cornelia L. Dekker, Matthew Z. Dudley, Barney S. Graham, Marc Gurwith, BARBARA J. LAW, Stanley M. Perlman, Fernando P. Polack, Jonathan M. Spergel et al. · 2021 · Vaccine
  62. A Review on SERS-Based Detection of Human Virus Infections: Influenza and Coronavirus
    Fernanda Saviñon-Flores, Erika Méndez, Mónica López-Castaños, Alejandro Carabarín‐Lima, Karen A. López-Castaños, Miguel A. González‐Fuentes, Alia Méndez‐Albores · 2021 · Biosensors
  63. Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients
    Xiaoping Chen, Wenjia Hu, Jiaxin Ling, Pingzheng Mo, Yongxi Zhang, Qunqun Jiang, Zhiyong Ma, Qian Cao, Liping Deng, Shihui Song et al. · 2020 · medRxiv
  64. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19
    Teluguakula Narasaraju, Benjamin M. P. Tang, Martin Herrmann i, Sylviane Muller, Vincent T. K. Chow, Marko Z. Radic · 2020 · Frontiers in Pharmacology
  65. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
    Lingling Tang, Yingan Jiang, Mengfei Zhu, Lijun Chen, Xiaoyang Zhou, Chenliang Zhou, Peng Ye, Xiaobei Chen, Baohong Wang, Zhenyu Xu et al. · 2020 · Frontiers of Medicine
  66. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature
    Filippo Migliorini, Ernesto Torsiello, Filippo Spiezia, Francesco Oliva, Markus Tingart, Nicola Maffulli · 2021 · European journal of medical research
  67. Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients
    Yingxia Liu, Fengming Huang, Jun Xu, Penghui Yang, Yuhao Qin, Mengli Cao, Zhaoqin Wang, Xiaohe Li, Shaogeng Zhang, Lu Ye et al. · 2020 · medRxiv
  68. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
    Christopher J. Rogers, Robert J. Harman, Bruce Alan Bunnell, Martin A. Schreiber, Charlie C. Xiang, Fu‐Sheng Wang, Antonio F. Santidrián, Boris Minev · 2020 · Journal of Translational Medicine
  69. Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial
    Wei‐jie Guan, Chun-Hua Wei, Ai-lan Chen, Xiao-Cong Sun, Guangyun Guo, Xu Zou, Jin-Dong Shi, Peizhen Lai, Zeguang Zheng, Nanshan Zhong · 2020 · Journal of Thoracic Disease
  70. Impact of climate and ambient air pollution on the epidemic growth during COVID-19 outbreak in Japan
    Kenichi Azuma, Naoki Kagi, Hoon Kim, Motoya Hayashi · 2020 · Environmental Research
  71. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement
    Gaetano Bulfamante, Gianluca Lorenzo Perrucci, Monica Falleni, Elena Sommariva, Delfina Tosi, Carla Martinelli, Paola Songia, Paolo Poggio, Stefano Carugo, Giulio Pompilio · 2020 · Biomedicines
  72. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study
    Ming Hu, Qiang Zhou, Ruiqiang Zheng, Xuyan Li, Jianmin Ling, Yumei Chen, Jing Jia, Cuihong Xie · 2020 · BMC Pulmonary Medicine
  73. Immune dysregulation and system pathology in COVID-19
    Muhammad Jamal, Hina Iqbal Bangash, Maria Habiba, Yufei Lei, Tian Xie, Jiaxing Sun, Zimeng Wei, Zixi Hong, Liang Shao, Qiuping Zhang · 2021 · Virulence
  74. Pathological findings in organs and tissues of patients with COVID-19: A systematic review
    Sasha Peiris, Hector A. Mesa, Agnes E. Aysola, Juan Carlos Manivel, João Toledo, Marcío Borges-Sa, Sylvain Aldighieri, Ludovic Revéiz · 2021 · PLoS ONE
  75. The Role of Artificial Intelligence in Tackling COVID-19
    Neelima Arora, Amit Kumar Banerjee, Mangamoori L Narasu · 2020 · Future Virology
  76. COVID-19, MERS and SARS with Concomitant Liver Injury—Systematic Review of the Existing Literature
    Michał Kukla, Karolina Skonieczna‐Żydecka, Katarzyna Kotfis, Dominika Maciejewska, Igor Łoniewski, Luis F. Lara, Monika Pazgan−Simon, Ewa Stachowska, Mariusz Kaczmarczyk, Anastasios Koulaouzidis et al. · 2020 · Journal of Clinical Medicine
  77. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients—indications for predictive, preventive, and personalized medical approach
    Xiaofang Zhao, Kun Wang, Peiyuan Zuo, Yuwei Liu, Meng Zhang, Songpu Xie, Hao Zhang, Xinglin Chen, Chengyun Liu · 2020 · The EPMA Journal
  78. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
    Frank M.P. van Haren, Clive Peter Page, John Gerard Laffey, Antonio Artigas, Marta Camprubí–Rimblas, Quentin M Nunes, Roger J. Smith, Janis Kay Shute, Mary Carroll, Julia A. Tree et al. · 2020 · Critical Care
  79. Rheumatological complications of Covid 19
    Hannah Zacharias, Shirish Dubey, Gouri Koduri, David P. D’Cruz · 2021 · Autoimmunity Reviews
  80. The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
    Maria Sofia Basile, Eugenio Cavalli, James Andrew McCubrey, Jorge Hernández‐Bello, José Francisco Muñóz-Valle, Paolo Fagone, Ferdinando Nicoletti · 2021 · Drug Discovery Today
  81. Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients
    Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, Benedetta Stancanelli, Michele Colaci, Giuseppe Natoli, Mario Russo, Innocenza Alessandria, Massimo Motta, Nicola Santangelo et al. · 2022 · Journal of Clinical Medicine
  82. Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled Trial
    Lei Shi, Xin Yuan, Weiqi Yao, Siyu Wang, Chao Zhang, Bo Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Junliang Fu et al. · 2021 · EBioMedicine
  83. Management of Heart Failure Patients with COVID-19: A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology
    Yuhui Zhang, Andrew J.S. Coats, Zhe Zheng, Marianna Adamo, Giuseppe Ambrosio, Stefan D. Anker, Javed Butler, Dingli Xu, Jingyuan Mao, Muhammad Shahzeb Khan et al. · 2020 · European Journal of Heart Failure
  84. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage
    Kristijan Skok, Evelyn Stelzl, Michael A Trauner, Harald H. Kessler, Sigurd Lax · 2020 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  85. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy
    Tewodros Shibabaw · 2020 · Journal of Inflammation Research
  86. Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysis
    Ashish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Shahid Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, Aran Deol, Benedict Francis et al. · 2020 · Annals of Hepatology
  87. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
    Fabrizio Cantini, Delia Goletti, Linda Petrone, Saeid Najafi Fard, Laura Niccoli, Rosario Foti · 2020 · Drugs
  88. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review
    Stefania Caramaschi, Meghan Kapp, Sara Miller, Rosana Eisenberg, Joyce E. Johnson, Garretson Epperly, Antonino Maiorana, Guido Silvestri, Giovanna A. Giannico · 2021 · Modern Pathology
  89. Pulmonary pathology of early‐phase COVID‐19 pneumonia in a patient with a benign lung lesion
    Zhi Rong Zeng, Li Xu, Xiao‐Yu Xie, Honglin Yan, Baojun Xie, Wanzhou Xu, Xin‐An Liu, Ganjun Kang, Wanli Jiang, Jingping Yuan · 2020 · Histopathology
  90. Severe COVID-19: A Review of Recent Progress With a Look Toward the Future
    Peng Xie, Wanyu Ma, Hongbo Tang, Daishun Liu · 2020 · Frontiers in Public Health
  91. Probiotics and Covid-19
    Benedetta Bottari, Vincenzo Castellone, Erasmo Neviani · 2020 · International Journal of Food Sciences and Nutrition
  92. Review on 3D printing: Fight against COVID-19
    Bankole Ibrahim Oladapo, Sikiru Oluwarotimi Ismail, Temitope D. Afolalu, David B. Olawade, Mohsen Zahedi · 2020 · Materials Chemistry and Physics
  93. Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019
    Ruizhong Ye, Xianlong Zhou, Fei Shao, Linfei Xiong, Jun Hong, Haijun Huang, Weiwei Tong, Jing Wang, Shuangxi Chen, Ailin Cui et al. · 2020 · CHEST Journal
  94. Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients
    Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, Irene del Molino del Barrio, Adam G. Laing, Thomas S. Hayday, Leticia Monin, Miguel Muñoz‐Ruiz, Louisa McDonald, Isaac Francos-Quijorna et al. · 2021 · Cancer Cell
  95. Correcting under-reported COVID-19 case numbers: estimating the true scale of the pandemic
    Kathleen M. Jagodnik, Forest Ray, Federico Manuel Giorgi, Alexander Lachmann · 2020 · medRxiv
  96. Pathological Role of Angiotensin II in Severe COVID-19
    Wolfgang Miesbach · 2020 · TH Open
  97. Pathologic features of COVID-19: A concise review
    Mohammadreza Tabary, Shaghayegh Khanmohammadi, Farnaz Araghi, Sahar Dadkhahfar, Seyed Mohammad Tavangar · 2020 · Pathology - Research and Practice
  98. A comparison of COVID-19, SARS and MERS
    Tingting Hu, Ying Liu, Mingyi Zhao, Quan Zhuang, Linyong Xu, Qingnan He · 2020 · PeerJ
  99. Probiotics: A potential immunomodulator in COVID-19 infection management
    Kuljit Singh, Alka Rao · 2021 · Nutrition Research
  100. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature
    Sivaporn Gatechompol, Anchalee Avihingsanon, Opass Putcharoen, Kiat Ruxrungtham, Daniel R. Kuritzkes · 2021 · AIDS Research and Therapy